INDP — Indaptus Therapeutics Share News
0.000.00%
Last trade - 00:00- $459.21m
- $447.65m
Brief: Indaptus Therapeutics - To Issue 20 Million Shares At $0.6 Per Share - SEC Filing
NASDAQ RESUMED AT 12:57 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:47 PM
Indaptus Therapeutics Q1 net loss narrows as expenses fall
Chief Executive Officer
Indaptus Therapeutics Q3 profit beats estimates
Brief: Indaptus Therapeutics Provides Clinical Update
Brief: Indaptus Therapeutics Announces Reverse Stock Split
Brief: Indaptus Therapeutics Announces Sale Of $2.3 Million In Private Placement Of Convertible Notes And Warrants
Brief: Indaptus Therapeutics reports full-year loss of $1.61 per share
Brief: Indaptus Therapeutics Expands Patent Portfolio In China, Japan, And Israel, Strengthening Its Intellectual Property For Infectious Disease And Cancer Treatments
Brief: Indaptus Therapeutics Enters Equity Purchase Agreement With Ya II Pn
Brief: Indaptus Therapeutics Files Prospectus Relating To Proposed Resale By Selling Stockholders Of Up To 4.4 Million Shares
Brief: Indaptus Therapeutics Inc - Not In Compliance With Nasdaq Minimum Bid Price Requirements
Brief: Indaptus Therapeutics Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Brief: Indaptus Therapeutics Provides Year-End Review And Outlook For 2025
Brief: Indaptus Therapeutics Announces $2.135 Million Registered Direct Offering And Concurrent Private Placement
U.S. RESEARCH ROUNDUP- AMN Healthcare Services, Chart Industries, Home Depot
Brief: Indaptus Therapeutics Announces Clinical Supply Agreement With Beigene To Evaluate Novel Cancer Treatment Combinations